Caption Management, LLC Mirati Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

18 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $923,780 - $1.37 Million	22,000 Added 26.8%	104,100 $6.12 Million
Q3 2023 Nov 14, 2023	BUY	$27.8 - $45.35 $2.28 Million - $3.72 Million	82,100 New	82,100 $3.58 Million
Q4 2022 Feb 14, 2023	BUY	$41.27 - $98.62 $1.16 Million - $2.76 Million	28,000 Added 28.0%	128,000 $5.8 Million
Q3 2022 Nov 14, 2022	BUY	$59.5 - $86.7 $3.21 Million - $4.68 Million	54,000 Added 117.39%	100,000 $6.98 Million
Q2 2022 Aug 15, 2022	SELL	$39.16 - $88.71 $3.6 Million - $8.15 Million	-91,900 Reduced 66.64%	46,000 $3.09 Million
Q4 2021 Feb 11, 2022	SELL	$132.01 - $190.29 $12.2 Million - $17.5 Million	-92,200 Reduced 40.07%	137,900 $20.2 Million
Q3 2021 Nov 12, 2021	BUY	$132.13 - $177.45 $26.8 Million - $36 Million	202,600 Added 736.73%	230,100 $40.7 Million
Q1 2021 May 17, 2021	SELL	$158.92 - $221.61 $3.58 Million - $4.99 Million	-22,500 Reduced 45.0%	27,500 $4.71 Million
Q4 2020 Feb 16, 2021	SELL	$162.05 - $240.27 $7.76 Million - $11.5 Million	-47,900 Reduced 48.93%	50,000 $11 Million
Q3 2020 Nov 16, 2020	BUY	$113.26 - $167.27 $3.73 Million - $5.5 Million	32,900 Added 50.62%	97,900 $16.3 Million
Q2 2020 Aug 14, 2020	SELL	$72.01 - $120.39 $3.83 Million - $6.4 Million	-53,200 Reduced 45.01%	65,000 $7.42 Million
Q1 2020 May 15, 2020	SELL	$69.78 - $116.21 $5.31 Million - $8.84 Million	-76,100 Reduced 39.17%	118,200 $9.08 Million
Q4 2019 Feb 13, 2020	BUY	$70.76 - $128.86 $7.87 Million - $14.3 Million	111,200 Added 133.81%	194,300 $25 Million
Q3 2019 Nov 14, 2019	SELL	$77.91 - $109.6 $13.6 Million - $19.1 Million	-174,100 Reduced 67.69%	83,100 $6.48 Million
Q2 2019 Aug 13, 2019	BUY	$59.49 - $104.71 $15.3 Million - $26.9 Million	257,100 Added 257100.0%	257,200 $26.5 Million
Q1 2019 May 14, 2019	BUY	$43.65 - $78.95 $4,365 - $7,895	100 New	100 $7,000
Q4 2018 Jan 30, 2019	SELL	$32.0 - $47.43 $854,400 - $1.27 Million	-26,700 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$47.1 - $62.7 $1.26 Million - $1.67 Million	26,700 New	26,700 $1.26 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account